ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Recent proteomic interrogation of CML LSCs has largely focused on the identification of dysregulated kinase activities in LSCs as numerous BCR-ABL-independent mechanisms of resistance in CML begin to emerge [196,197].